Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $157000.0.

  • Niagen Bioscience's Depreciation and Depletion fell 426.83% to $157000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $624000.0, marking a year-over-year decrease of 943.4%. This contributed to the annual value of $663000.0 for FY2024, which is 2379.31% down from last year.
  • As of Q3 2025, Niagen Bioscience's Depreciation and Depletion stood at $157000.0, which was down 426.83% from $158000.0 recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Depreciation and Depletion peaked at $235000.0 during Q3 2022, and registered a low of $151000.0 during Q4 2024.
  • Moreover, its 5-year median value for Depreciation and Depletion was $211000.0 (2021), whereas its average is $198157.9.
  • As far as peak fluctuations go, Niagen Bioscience's Depreciation and Depletion soared by 1343.28% in 2023, and later tumbled by 2961.37% in 2024.
  • Quarter analysis of 5 years shows Niagen Bioscience's Depreciation and Depletion stood at $211000.0 in 2021, then grew by 4.74% to $221000.0 in 2022, then decreased by 19.91% to $177000.0 in 2023, then fell by 14.69% to $151000.0 in 2024, then increased by 3.97% to $157000.0 in 2025.
  • Its Depreciation and Depletion stands at $157000.0 for Q3 2025, versus $158000.0 for Q2 2025 and $158000.0 for Q1 2025.